219 related articles for article (PubMed ID: 24721139)
21. Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins.
Machado-Alba JE; Medina-Morales DA; Echeverri-Cataño LF
Expert Opin Drug Saf; 2017 Feb; 16(2):133-137. PubMed ID: 28002970
[TBL] [Abstract][Full Text] [Related]
22. Factors contributing to non-adherence to diabetes treatment among diabetic patients attending clinic in Mwanza city.
Fedrick F; Justin-Temu M
East Afr J Public Health; 2012 Sep; 9(3):90-5. PubMed ID: 23136703
[TBL] [Abstract][Full Text] [Related]
23. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
Goldstein HH
Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
[TBL] [Abstract][Full Text] [Related]
24. Clarifying responsibility for self-management of diabetes in adolescents using insulin pumps--a qualitative study.
Olinder AL; Nyhlin KT; Smide B
J Adv Nurs; 2011 Jul; 67(7):1547-57. PubMed ID: 21323979
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
[TBL] [Abstract][Full Text] [Related]
26. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
27. Low discomfort and pain associated with intensified insulin therapy in children and adolescents.
Karges B; Muche R; Moritz M; Riegger I; Debatin KM; Heinze E; Wabitsch M; Karges W
Diabetes Res Clin Pract; 2008 Apr; 80(1):96-101. PubMed ID: 18160119
[TBL] [Abstract][Full Text] [Related]
28. The role of coping with disease in adherence to treatment regimen and disease control in type 1 and insulin treated type 2 diabetes mellitus.
Turan B; Osar Z; Molzan Turan J; Damci T; Ilkova H
Diabetes Metab; 2002 Jun; 28(3):186-93. PubMed ID: 12149598
[TBL] [Abstract][Full Text] [Related]
29. Medication adherence in type 2 diabetes patients in Nigeria.
Jackson IL; Adibe MO; Okonta MJ; Ukwe CV
Diabetes Technol Ther; 2015 Jun; 17(6):398-404. PubMed ID: 25749392
[TBL] [Abstract][Full Text] [Related]
30. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
[TBL] [Abstract][Full Text] [Related]
31. Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes.
Negarandeh R; Mahmoodi H; Noktehdan H; Heshmat R; Shakibazadeh E
Prim Care Diabetes; 2013 Jul; 7(2):111-8. PubMed ID: 23195913
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
Batais MA; Schantter P
Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
[TBL] [Abstract][Full Text] [Related]
33. [Insulin injection technique, practices observed by patients and nurses].
Kakou B; Artus B; Barcos I; Durain D; Gilbert C; Boudrot E; Laroche F; Leridon L; Mater D
Soins; 2010 May; (745):18, 20. PubMed ID: 20509483
[TBL] [Abstract][Full Text] [Related]
34. [A new therapeutic option for diabetes patients].
Mihălţan F; Ulmeanu R; Râşnoveanu R
Pneumologia; 2005; 54(4):181-5. PubMed ID: 17069221
[TBL] [Abstract][Full Text] [Related]
35. Diabetes through the ages.
Neithercott T
Diabetes Forecast; 2014 Jan; 67(1):36-9. PubMed ID: 25868293
[No Abstract] [Full Text] [Related]
36. A quantitative assessment of patient barriers to insulin.
Casciano R; Malangone E; Ramachandran A; Gagliardino JJ
Int J Clin Pract; 2011 Apr; 65(4):408-14. PubMed ID: 21401829
[TBL] [Abstract][Full Text] [Related]
37. Considerations for diabetes: treatment with insulin pen devices.
Cuddihy RM; Borgman SK
Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
[TBL] [Abstract][Full Text] [Related]
38. Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: The roles of diabetes distress and current medication concerns. Results from Diabetes MILES--Australia.
Holmes-Truscott E; Skinner TC; Pouwer F; Speight J
Prim Care Diabetes; 2016 Feb; 10(1):75-82. PubMed ID: 26150327
[TBL] [Abstract][Full Text] [Related]
39. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals.
Bailey T; Thurman J; Niemeyer M; Schmeisl G
Curr Med Res Opin; 2011 Oct; 27(10):2043-52. PubMed ID: 21916529
[TBL] [Abstract][Full Text] [Related]
40. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
